The cooperation between the influx of extracellular calcium and α1-adrenoceptor-induced translocation of protein kinase C

Pharmacological Research

Volumn 36, Issue 3, 1997, Pages 211-219

  Szmigielski, A ^a   Szmigielska, H ^a   Zalewska Kaszubska, J ^a   Marczak, G ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Protein kinase C translocation; 1 adrenoceptor, clcium channel blockers

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CALCIMYCIN; CALCIUM CHANNEL; CALCIUM ION; NIFEDIPINE; PHENYLEPHRINE; PRAZOSIN; PROTEIN KINASE C; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; DOSE RESPONSE; ENZYME ACTIVATION; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031234486     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0229     Document Type: Article

References (31)

1. 2 activity. J Biol Chem 1987; 262: 11764-11770.
2. 2. Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 192; 258: 607-14.
3. 3. Nalepa I, Vetulani J. Enhancement of the responsiveness of cortical adrenergic receptors by chronic administration of the 5-hydroxytryptamine uptake inhibitor citalopram. J Neurochem 1993; 60: 2029-35.
4. 4. Mithell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995; 76: 73-81.
5. 5. Nahorski SR. Inositol polyphosphates and neuronal calcium homeostasis. Trends Neurosci 1988; 11: 444-8.
6. 6. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature 1989; 341: 197-205.
7. 7. Gautvik KM, Wright M, Karlsen HE, Sand O. Hormone receptors and cellular signal transduction. Scand J Clin Lab Invest Suppl 1990; 202: 123-126.
8. 8. Berridge MJ. Inositol triphosphate and calcium signalling. Nature 1993; 361: 315-25.
9. 9. Guy GR, Gordon J, Walker L. Mitchell RH, Brown G. Redistribution of protein kinase C during mitogenesis of human B lymphocytes. Biochem Biophys Res Commun 1986; 135: 146-53.
10. 10. Ginsberg J, Murray PG, Parente JE, Wong K. Translocation of protein kinase C in porcine thyroid cells following exposure to thyrothropin. FEBS Lett 1988; 226: 223-6.
11. 11. Parker PJ, Kour G, Marais RM, Mitchell F, Pears C, Schaap D, Stabel S, Webster C. Protein kinase C - a family affair. Mol Cell Endocrinol 1989; 65: 1-11.
12. 12. Oda T, Shearman MS, Nishizuka Y. Synaptosomal protein kinase C subspecies: B. Down regulation promoted by phorbol ester and its effect on evoked norepinephrine release. J Neurochem 1991; 56: 1263-9.
13. 13. Ha KS, Exton JH. Differential translocation of protein kinase C isoenzymes by thrombin and platelet - derived growth factor. A possible function for phosphatidylcholine - derived diacylglycerol. J Biol Chem 1993; 268: 10534-9.
14. 14. Chakravarthy BR, Whitfield JF, Durkin JP. Inactive membrane protein kinase Cs: a possible target for receptor signalling. Biochem J 1994; 304: 809-16.
15. 15. Shearman MS, Sekiguchi K, Nishizuka Y. Modulation of ion channel activity: a key function of protein kinase C enzyme family. Pharmacol Rev 1989; 41: 211-37.
16. 16. Huang HY, Allgaier C, Herttig G, Jackisch R. Phorbol ester-mediated enhancement of hippocampal noradrenaline release: which ion channels are involved? Eur J Pharmacol 1988; 153: 175-184.
17. 2+ uptake, and the enzyme activity. J Neurochem 1988; 51: 967-74.
18. 2+ channel. Eur J Pharmacol 1989; 162: 59-66.
19. 19. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
20. 20. Pucilowski O. Psychopharmacological properties of calcium channel inhibitors. Psychopharmacology 1992; 109: 12-29.
21. 2+ release in permeabilized pancreatic acinar cells by hormonal and phorbol ester pretreatment. J Biol Chem 1989; 264: 9762-7.
22. 22. Lambert DG, Nahorski SR. Carbachol-stimulated calcium entry in SH-SY5Y human neuroblastoma cells: which route? J Physiol 1992; 86: 77-82.
23. 23. Gleason MM, Flaim SF. Phorbol ester contracts rabbit thoracic aorta by increasing intracellular calcium and by activating calcium influx. Biochem Biophys Res Commun 1986; 138: 1362-9.
24. 2+ utilization in the contraction of rat aorta to stimulation of protein kinase C by phorbol dibutyrate. J Pharmacol Exp Ther 1987; 242: 934-9.
25. 25. Singer HA, Baker KM. Calcium dependence of phorbol 12,13-dibutyrate-induced force and myosin light chain phosphorylation in arterial smooth muscle. J Pharmacol Exp Ther 1987; 243: 814-21.
26. 26. Turla MB, Webb RC. Enhanced vascular reactivity to protein kinase C activators in genetically hypertensive rats. Hypertension 1987; 9:III 150-4.
27. 27. Abebe W, MacLeod KM. Protein kinase C-mediated contractile responses of arteries from diabetic rats. Br J Pharmacol 1990; 101: 465-71.
28. 28. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U. IV. International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol Rev 1994; 46: 121-36.
29. 29. Ruffolo RR Jr, Nichols AJ. The relationship of reserve and antagonist efficacy to the sensitivity of α-adrenoceptor-mediated vasopressor responses to inhibition by calcium channel antagonists. Ann NY Acad Sci 1988; 522: 361-76.
30. 2+ influx. Mol Pharmacol 1989; 36: 166-76.
31. 1-Adrenergic receptor subtypes, inositol phosphates and sources of cell calcium. Pharmacol Rev 1988; 40: 87-119.